6-8
Oct
2026
CPHI Milan 2026
Fiera Milano, Italy
3K118

SHANGHAI JINDUN INDUSTRIAL CO.,LTD

About SHANGHAI JINDUN INDUSTRIAL CO.,LTD

JIN DUN Medical Research lnstitute is affiliated to Shghai JINDUN Industrial Co., Ltd., headquartered in Shanghai. adiacent tHongqiao High-speed Railway Station and Hongqiao Internationl airport. JIN DUN Medical Research Institute is committed toproviding pharmaceutical intermediates and raw materials withthe purpose of innovative drug researchCustomized R&D anccustomized production services.

Meet us at

  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026
  • Country/Region:
    China
  • On CPHI since:
    2023
  • Employees:
    100 - 249
Company types
Distributor/Import Export
Contact info
  • NO.9, Lane 3599, Qi Xin Road,, 201101, Shanghai, Shanghai, China

Products from SHANGHAI JINDUN INDUSTRIAL CO.,LTD (10)

  • Empagliflozin

    Product Empagliflozin

    Basic InfoGrade: Pharmaceutical Grade Factory Location: China Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa Sample Provided: yes Payment Terms: L/C Product Name: Empagliflozin Cas No.:&nbs...
  • Linagliptin

    Product Linagliptin

    产品名:利格列汀 CAS 编号: 668270-12-0 分子式: C25H28N8O2 分子式: 472.54 EINECS编号: 1308068-626-2 熔点:202 ºC 沸点:661.2±65.0°C(预测) 密度:1.39 应用:抗糖尿病

  • Nifedipine

    Product Nifedipine

    Long-term coronary vasodilators. This product can increase coronary blood flow, reducing myocardial oxygen consumption.it is used for acute and chronic coronary insufficiency,especially the angina and myocardial infarction.
  • Sitagliptin phosphate monohydrate

    Product Sitagliptin phosphate monohydrate

    sitagliptin phosphate monohydrate is the phosphate salt of its active component, sitagliptin, with one molecule of water. sitagliptin is a potent inhibitor of dipeptidyl peptidase 4 (dpp-4), an enzyme catalyzing the cleavage of peptides with an n-terminal alanine or proline amino acid residue, that selecti...
  • Valsartan

    Product Valsartan

    Valsartan is a type of specific angiotensin I (AT1) receptor antagonist and a clinical non-dermal AT1 receptor antagonist following losartan that has important effects in adjusting bodily blood pressure and maintaining electrolyte-body fluid balance. Valsartan’s antihypertensive effects are stronger than t...
  • Valsartan

    Product Valsartan

    Valsartan is a type of specific angiotensin I (AT1) receptor antagonist and a clinical non-dermal AT1 receptor antagonist following losartan that has important effects in adjusting bodily blood pressure and maintaining electrolyte-body fluid balance. Valsartan’s antihypertensive effects are stronger than t...
  • Valsartan

    Product Valsartan

    Valsartan is a type of specific angiotensin I (AT1) receptor antagonist and a clinical non-dermal AT1 receptor antagonist following losartan that has important effects in adjusting bodily blood pressure and maintaining electrolyte-body fluid balance. Valsartan’s antihypertensive effects are stronger than t...
  • Valsartan

    Product Valsartan

    Valsartan is a type of specific angiotensin I (AT1) receptor antagonist and a clinical non-dermal AT1 receptor antagonist following losartan that has important effects in adjusting bodily blood pressure and maintaining electrolyte-body fluid balance. Valsartan’s antihypertensive effects are stronger than t...
  • Valsartan

    Product Valsartan

    Valsartan is a type of specific angiotensin I (AT1) receptor antagonist and a clinical non-dermal AT1 receptor antagonist following losartan that has important effects in adjusting bodily blood pressure and maintaining electrolyte-body fluid balance. Valsartan’s antihypertensive effects are stronger than t...
  • Valsartan

    Product Valsartan

    Valsartan is a type of specific angiotensin I (AT1) receptor antagonist and a clinical non-dermal AT1 receptor antagonist following losartan that has important effects in adjusting bodily blood pressure and maintaining electrolyte-body fluid balance. Valsartan’s antihypertensive effects are stronger than t...